Sleep

Bedwetting medicine ‘out of stock’ until mid-September, warns CPE

The government has warned that bedwetting medication Desmopressin is in short supply.

'Euros anxiety’ leads to 209% magnesium sales spike

Superdrug has reported a 209% rise in sales of magnesium tablets to combat the UK's "summer of stress" due to Euro 2024, the general election and changeable weather.

Dispenser sentenced for stealing thousands of sleeping pills

Cambridgeshire Constabulary has announced that a pharmacy dispenser has been handed a suspended sentence for theft by an employee of thousands of temazepam tablets.

Is helping patients sleep better a trivial pursuit?

After attending the Pharmacy Show this week, Adrian Zacher discusses his preferred way to promote sleep-focused products in community pharmacy

How can pharmacists spot sleeping tablet addiction and respond to it?

A professional footballer's sleeping tablet addiction admission has highlighted that urgent attention and intervention are necessary, says Shilpa Patel

Crisis, what crisis? MPs must help tackle sleep disorder problems now

Community pharmacists cannot hold the frontline in the battle against sleep disorders on their own, warns Adrian Zacher

What can community pharmacists do to help their patients with ADHD?

Peter Kelly spoke to one of his patients about their journey with adult attention-deficit hyperactivity disorder (ADHD)

Now is the time for community pharmacy to help patients with sleep disorders

With increasing rates of sleep disorders, the time to help patients with these ailments is now, says Adrian Zacher 

MHRA approves melatonin solution for children and adolescents with ADHD

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Colonis’ Melatonin 1mg/ml Oral Solution as a treatment to improve sleep in children and adolescents with attention-deficit hyperactivity disorder (ADHD), the manufacturer has announced.

MHRA issues medicines defect alert for zopiclone tablets

Zopiclone 3.75mg and 7.5mg tablets made by Ratiopharm, and zopiclone 3.75mg tablets made by Mylan are missing “important safety information”, the MHRA has warned.